Department of Pediatrics, University of Tartu, Tartu, Estonia.
Diabetes Metab Res Rev. 2012 Jul;28(5):455-61. doi: 10.1002/dmrr.2303. Epub 2012 Apr 10.
Human leukocyte antigen (HLA) genotypes associated with increased risk for type 1 diabetes mellitus (T1D) have been reported to be associated with increased birth weight. We set out to investigate the association between HLA haplotypes conferring risk for T1D and birth weight and search for possible differences in the strength of these associations among populations with contrasting incidence of T1D.
As a part of the EU-funded DIABIMMUNE study, genotyping for the HLA haplotypes associated with T1D was performed in 8369 newborn infants from Estonia, Finland and Russian Karelia. Infants born before 35 gestational weeks, from mothers with diabetes, and multiple pregnancies were excluded. Relative birth weight, expressed in standard deviation scores, was estimated for each gestational week, sex and country. The standard deviation scores were calculated internally using the actual population studied. According to their HLA haplotypes, participants were divided into risk groups, and the distribution of birth weight between quartiles was analysed.
We did not find any direct association between various HLA risk-associated genotypes (HLA DR3-DQ2/DR4-DQ8, DR3-DQ2/X or DR4-DQ8/X) and birth weight. We observed a significant relationship between increased relative birth weight and the protective HLA-DR2-DQ6 and DR13-DQ6 haplotypes. This association was significant only when these haplotypes were found together with the DR4-DQ8 haplotype.
The previously reported association between HLA-risk haplotypes for T1D and an increased birth weight was not confirmed. This suggests that the mechanisms behind the association between high birth weight and risk for T1D may be not directly HLA related.
与 1 型糖尿病(T1D)风险增加相关的人类白细胞抗原(HLA)基因型已被报道与出生体重增加有关。我们着手调查与 T1D 风险相关的 HLA 单倍型与出生体重之间的关联,并寻找在 T1D 发病率不同的人群中这些关联强度的可能差异。
作为欧盟资助的 DIABIMMUNE 研究的一部分,在爱沙尼亚、芬兰和俄罗斯卡累利阿的 8369 名新生儿中进行了与 T1D 相关的 HLA 单倍型基因分型。排除了胎龄小于 35 周、母亲患有糖尿病和多胎妊娠的婴儿。根据每个胎龄、性别和国家,估计相对出生体重,以标准差分数表示。使用实际研究的人群在内部计算标准差分数。根据他们的 HLA 单倍型,参与者被分为风险组,并分析了四分位出生体重的分布。
我们没有发现各种 HLA 风险相关基因型(HLA DR3-DQ2/DR4-DQ8、DR3-DQ2/X 或 DR4-DQ8/X)与出生体重之间存在直接关联。我们观察到相对出生体重增加与保护性 HLA-DR2-DQ6 和 DR13-DQ6 单倍型之间存在显著关系。当这些单倍型与 DR4-DQ8 单倍型一起发现时,这种关联才具有统计学意义。
先前报道的 T1D 风险 HLA 单倍型与出生体重增加之间的关联并未得到证实。这表明高出生体重与 T1D 风险之间的关联背后的机制可能与 HLA 无关。